Inmedix, Inc.

BiotechnologyBiotechnologyMedical DiagnosticsDiagnostics Platform

📍 Normandy Park, WA, USA• 1-10 employees

StreetZero Signal 75

Be the first to signal interest

About Inmedix, Inc.

Inmedix®, Inc. is a medical diagnostics company pioneering the field of stress biology through its FDA-cleared CloudHRV® platform. The company is headquartered in Normandy Park, WA and has approximately 7 employees. It focuses on developments in stress biology and related diagnostic capabilities.

LATEST FUNDINGPrivate Placement

$4.0M

Announced 2026-10-22

TOTAL RAISED$4,009,945

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Inmedix, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES1-10

FOUNDED—

HQNormandy Park, WA, USA

Industry

Biotechnology

Tags

BiotechnologyMedical DiagnosticsDiagnostics Platform

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

FDA-cleared CloudHRV platform for stress biology diagnostics.
Completed $4M private placement with undisclosed investors.
Founder and CEO is Andrew J. Holman.
Headquartered in Normandy Park, WA with 7 employees.

Ask StreetZero about Inmedix, Inc.

Put our AI to work on this deal.

What is Inmedix, Inc.'s value proposition?Who are Inmedix, Inc.'s competitors?Why does this raise matter?Summarize Inmedix, Inc. for an investor.

Similar companies

Other Biotechnology deals, ranked by Signal.

Allyx Therapeutics, Inc.

Estuary Biotherapeutics, Inc.

CURADEL SURGICAL INNOVATIONS, INC.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account